Wp Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wp Advisors, LLC

$316 Million
Q2 2024

A detailed history of Wp Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wp Advisors, LLC holds 2,611 shares of REGN stock, worth $2.17 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

2,611

Previous 2,776 5.94%

Holding current value

$2.17 Million

Previous $2.67 Million 2.73%

% of portfolio

0.87%

Previous 0.88%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$883.2 - $1071.19 $145,728 - $176,746	-165 Reduced 5.94%	2,611 $2.74 Million
Q1 2024 May 08, 2024	SELL	$902.69 - $993.35 $36,107 - $39,734	-40 Reduced 1.42%	2,776 $2.67 Million
Q4 2023 Jan 31, 2024	SELL	$775.18 - $881.7 $19,379 - $22,042	-25 Reduced 0.88%	2,816 $2.47 Million
Q3 2023 Oct 30, 2023	SELL	$692.45 - $844.37 $13,849 - $16,887	-20 Reduced 0.7%	2,841 $2.34 Million
Q2 2023 Jul 26, 2023	SELL	$700.03 - $830.35 $64,402 - $76,392	-92 Reduced 3.12%	2,861 $2.06 Million
Q4 2022 Jan 20, 2023	SELL	$705.89 - $766.39 $37,412 - $40,618	-53 Reduced 1.76%	2,953 $0
Q2 2022 Jul 12, 2022	SELL	$548.35 - $738.84 $26,869 - $36,203	-49 Reduced 1.6%	3,006 $1.78 Million
Q1 2022 Apr 25, 2022	SELL	$595.12 - $698.43 $65,463 - $76,827	-110 Reduced 3.48%	3,055 $2.13 Million
Q3 2021 Oct 20, 2021	SELL	$574.03 - $680.96 $17,220 - $20,428	-30 Reduced 0.94%	3,165 $1.92 Million
Q2 2021 Jul 22, 2021	BUY	$472.8 - $558.54 $85,576 - $101,095	181 Added 6.01%	3,195 $1.79 Million
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $1.35 Million - $1.65 Million	3,014 New	3,014 $1.43 Million

Others Institutions Holding REGN

# of Institutions

1,485

Shares Held

85.7M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wp Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wp Advisors, LLC with notifications on news.

Account